People channel feed – Endpoints News

People channel feed

Ex-FDA commish Scott Gottlieb says he's 'very proud' of Pfizer post as top Dem attacks influence peddling

6 years ago

Merrimack CEO, CFO bow out, months after last clinical drug fizzles

6 years ago

Investors trapped for another 28 days as suspension of Woodford flagship fund drags on

6 years ago

Neil Woodford refreshes portfolio with fire sale while investors ponder future of suspended fund

6 years ago

Tesaro vet jumps to an Irish oncology upstart and shifts focus to the US, eyeing fundraising

6 years ago

Scott Gottlieb tempts the FDA's fiercest critics with his leap onto Pfizer's board of directors

6 years ago

James Noble is taking his last lap at the biotech he founded, and saved. It's Adrian Rawcliffe's turn now

6 years ago

Following news of job cuts in European R&D ops, Sanofi confirms it’s offering US workers an 'early exit'

6 years ago

After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin

6 years ago

Eli Casdin backs Codexis' platform tech with $50M equity buy

6 years ago

Verastem CEO Forrester steps to the exit as the board hunts commercial-savvy exec for the beleaguered biotech

6 years ago

Who’s next in line to succeed Ken Frazier as CEO of the Keytruda-blessed Merck?

6 years ago

Chicago biotech argues bluebird, Third Rock 'killed' its rival, pioneering thalassemia gene therapy in lawsuit

6 years ago

Woodford braces political storm as UK financial regulators scrutinize fund suspension

6 years ago

Under siege, investment manager Woodford faces another investment shock

6 years ago

Turns out, Rudy Tanzi didn't see much of a story about a hidden link between Enbrel and Alzheimer's either

6 years ago

J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato

6 years ago

Roche catapults Thomas Schinecker to chief of diagnostics unit

6 years ago

Sanofi recruits Novartis' top pharma exec Paul Hudson as its new CEO — so what happens now?

6 years ago

Ex-Juno chief Hans Bishop takes the helm at cancer testing startup Grail in a shakeup as IPO rumors percolate

6 years ago

Clock starts ticking on Leif Johansson's retirement from AstraZeneca chairman role — report

6 years ago

Ned Sharpless weighs in on gene therapy pricing debate, suggesting 'the messaging got lost'

6 years ago

Bristol-Myers bumps off chief scientist in another big shakeup, bringing in Celgene and Novartis execs

6 years ago

Neil Woodford forcefully stems investor outflow by suspending his beleaguered main fund

6 years ago

First page Previous page 77 78 798081 82 83 Next page Last page